Ards clinical trials

Explore recruiting ards clinical trials.

Recruiting ards studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ards trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard of Care for Moderate-to-Severe ARDS Due to Pneumonia or Other Infections

Bulgaria, Netherlands, Germany, Czechia, Hungary, Italy +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

[68Ga]-FAPI PET/CT to detect fibroblast activity in non-resolving ARDS patients at the ICU.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0)

Spain, France, Romania, Germany, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of anakinra in non-COVID-19 related ARDS. ESKA study.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Ards trials by city

Ards in Toronto Ards in Vancouver Ards in Montreal Ards in Calgary Ards in Edmonton Ards in Ottawa Ards in Winnipeg Ards in Quebec City Ards in Hamilton Ards in Kitchener Ards in London Ards in Halifax Ards in New York Ards in Los Angeles Ards in Chicago Ards in Houston

Ards clinical trials

Recruiting ards studies right now

Nalbuphine in ARDS Patients After Surgery

Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Lung EIT Image Guide Ventilation in ARDS

Fluid Responsiveness Prediction During Prone Position

Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study.

MINImising Total Radiation EXposure in Preterm Infants

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

Trial of Therapeutic Hypothermia in Patients With ARDS

EIT-Guided Ventilator Settings in AHRF

Also recruiting in Europe

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard of Care for Moderate-to-Severe ARDS Due to Pneumonia or Other Infections

[68Ga]-FAPI PET/CT to detect fibroblast activity in non-resolving ARDS patients at the ICU.

Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0)

Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome

Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID)

Efficacy and safety of anakinra in non-COVID-19 related ARDS. ESKA study.

Ards trials by city

Other conditions